Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
Saavsus, Inc. · with Oregon Research Institute · NCT07203313
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 7+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1872
- US sites recruiting
- 2
- Study start
- September 1, 2025
- Record last updated
- October 2, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to evaluate the newly developed Pocket PE 3-5 app, designed for use by teachers of 3rd-, 4th-, and 5th-grade students. Researchers will compare teachers and students in classrooms using the Pocket PE app with those in classrooms not using the app.
The main question it aims to answer is
- Does the use of the Pocket PE 3-5 app improve classroom teacher PE self-efficacy and high-quality PE teaching behaviors, and promote students' moderate-to-vigorous physical activity participation in PE, as well as PE enjoyment and self-efficacy, compared to teachers who do not use Pocket PE 3-5?
Participants will
- Randomly use Pocket PE 3-5 (12 intervention schools) for at least one PE class weekly, or not (12 control schools), for 12 consecutive weeks during the 2025/26 school year.
- Teachers will complete short surveys at 0 weeks (pre), 6 weeks (mid), and 13 weeks (post). Teachers in the intervention condition will complete a longer survey at 13 weeks (post-intervention) to provide feedback on the Pocket PE app. A random sub-sample of teachers in the intervention condition will be asked to participate in an exit interview to give additional input on Pocket PE 3-5 after the intervention has been completed.
- Students will complete brief surveys after PE classes at pre, mid, and post, and will wear wrist heart rate monitors during observed PE classes at these timepoints to measure their physical activity during PE.
We will also evaluate the level of implementation of Pocket PE 3-5 among teachers via class observations and objective data collected by the app.
Being studied: Digital PE teaching app
Conditions: Teacher Self-efficacy for Teaching PE; Teacher PE Instruction; Student PE Enjoyment; Student Physical Activity; Student PE Satisfaction
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria for teachers
- A 3rd, 4th, or 5th grade teacher at a participating school responsible for teaching PE at least one time a week;
- Able to read and understand English;
- Willing to use Pocket PE to facilitate their PE class instruction for 12 weeks;
- Be able to understand the study and consent to participate
Inclusion Criteria for students
- A 3rd, 4th, or 5th grader enrolled in a participating class in a participating school;
- Able to read and understand English;
- Able to understand the study and assent to participation;
Exclusion Criteria
- None
Recruiting US locations
Saavsus, Inc.
Eugene, OR 97401
Oregon Research Institute
Springfield, OR 97477
Site contact: Erika Westling, PhD · 541-484-2123 · erikaw@ori.org
Study contacts (from the official record)
- Jeanette Ricci, PhD · 530-925-1516 · jeanettericci@saavsus.com
Similar studies in Oregon
All healthy volunteers studies in Oregon →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Bend, OR + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1/Phase 2
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 20–49
- RecruitingHealthy volunteersEarly Phase 1
Monoferric for Prenatal Iron Deficiency
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 18–65 · Women only
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Portland, OR + 55 other US sites
- Eligibility basics
- Ages 18–79